Key result
Higher left atrioventricular coupling index linked to ~45% higher SCD risk in HCM.
Why the study?
The prognostic value of the left atrioventricular coupling index (LACI) in predicting sudden cardiac death events in hypertrophic cardiomyopathy and its incremental value beyond guideline-based risk models was unclear.
Does CMR-derived left atrioventricular coupling index (LACI) improve prediction of sudden cardiac death events beyond guideline-based models in patients with hypertrophic cardiomyopathy?
Cohort (n=2,240)
Does CMR-derived left atrioventricular coupling index (LACI) improve prediction of sudden cardiac death events beyond guideline-based models in patients with hypertrophic cardiomyopathy?
Answers are grounded in this paper and cite their sources.
CMR-derived LACI provides incremental prognostic value beyond LGE and guideline-based models for predicting sudden cardiac death in patients with hypertrophic cardiomyopathy.
AIM: To assess the prognostic value of the left atrioventricular coupling index (LACI) in predicting sudden cardiac death (SCD) events in patients with hypertrophic cardiomyopathy (HCM), and to evaluate whether LACI provides incremental prognostic information beyond guideline-based risk models. MATERIALS AND METHODS: In this retrospective study, 2,240 HCM patients were analysed. Clinical and cardiac magnetic resonance (CMR) parameters, including LACI, late gadolinium enhancement (LGE), and left ventricular ejection fraction (LVEF), were evaluated. LACI was defined as the ratio of left atrial end-diastolic volume to left ventricular end-diastolic volume. Univariable and multivariable Cox regression analyses assessed associations of LACI with SCD events and guideline-based models (European Society of Cardiology [ESC] and American College of Cardiology/American Heart Association [ACC/AHA]). RESULTS: Over a mean follow-up of 4.0 ± 2.5 years, 128 patients (5.7%) experienced SCD events. Event patients had higher LACI (39% ± 28% vs. 33% ± 23%, P = 0.04), greater LGE (12.1 ± 8.6% vs 6.4 ± 4.3%, P < 0.001), and lower LVEF (48 ± 15% vs 65 ± 13%, P < 0.001). LACI independently predicted SCD events after adjusting for LGE and conventional risk factors (multivariable hazard ratio [HR] 1.44-1.46, 95% confidence interval [CI]: 1.3-1.6; P < 0.001) in both ESC- and ACC/AHA-adjusted models. Adding LACI and LGE to the ESC model improved the area under the curve [AUC] (0.69 vs 0.53) and specificity (82.6% vs 57.9%). CONCLUSION: CMR-derived LACI independently predicts adverse outcomes in HCM and provides incremental prognostic value beyond LGE and guideline-based models.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) conducted a cohort in Hypertrophic cardiomyopathy (HCM) (n=2,240). Left atrioventricular coupling index (LACI) vs. Lower LACI / conventional risk models was evaluated on Sudden cardiac death (SCD) events (HR 1.44-1.46, 95% CI 1.3-1.6, p=<0.001). Higher left atrioventricular coupling index independently predicted sudden cardiac death events in patients with hypertrophic cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: